2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies
Open Access
- 1 January 1993
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 67 (1) , 139-143
- https://doi.org/10.1038/bjc.1993.24
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.Journal of Clinical Oncology, 1992
- 2-Chlorodeoxyadenosine treatment of lymphoid malignancies.1992
- On the pharmacokinetics of 2-chloro-2'-deoxyadenosine in humans.1991
- Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-ChlorodeoxyadenosineNew England Journal of Medicine, 1990
- BIOCHEMICAL PHARMACOLOGY OF 2-CHLORODEOXYADENOSINE IN MALIGNANT HUMAN HEMATOPOIETIC-CELL LINES AND THERAPEUTIC EFFECTS OF 2-BROMODEOXYADENOSINE IN DRUG-COMBINATIONS IN MICE1989
- 2-CHLORODEOXYADENOSINE - AN EFFECTIVE NEW AGENT FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA1988
- Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.Journal of Clinical Investigation, 1985
- SPECIFIC TOXICITY OF 2-CHLORODEOXYADENOSINE TOWARD RESTING AND PROLIFERATING HUMAN-LYMPHOCYTES1983
- Reporting results of cancer treatmentCancer, 1981
- Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.Proceedings of the National Academy of Sciences, 1980